Publication | Open Access

The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

Advanced Lung DiseaseLung InflammationStructural Lung DiseasePediatricsRespiratory InfectionPediatric Lung DiseasePulmonary FibrosisPulmonary MedicineCombat CfMedicinePulmonary Disease